Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $524.15 ($4.3M) on 2026-08-20, disclosed to the SEC on 2026-08-21.
Scheduled sale ($4.3M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $520.03 | 502 | $261K | 6.0% |
| 2 | $521.04 | 1,819 | $948K | 21.8% |
| 3 | $522.00 | 787 | $411K | 9.5% |
| 4 | $522.78 | 850 | $444K | 10.2% |
| 5 | $523.69 | 192 | $101K | 2.3% |
| 6 | $524.15 | 2,690 |
| $1.4M |
| 32.5% |
| 7 | $525.25 | 940 | $494K | 11.4% |
| 8 | $526.38 | 400 | $211K | 4.8% |
| 9 | $527.21 | 120 | $63K | 1.5% |
| Total | $523.14 avg | 8,300 | $4.3M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-07-16 | $4.4M | — | Filing → |